A deal covering new cystic fibrosis drugs is unlikely to happen unless the manufacturer Vertex agrees to drop its prices, NHS England has indicated. Vertex is seeking a deal to fund national access in England to its cystic fibrosis (CF) drug, Orka...
Original Article: Row over CF drug funding as NHS rejects Vertex offer
NEXT ARTICLE